Tribe Clinical Research in Greenville has announced the launch of a new trial for a drug centered around Alzheimer's ...

"ShiraTronics commences chronic migraine therapy trial" was originally created and published by Medical Device Network, a ...

Thermo Fisher's patent activity and acquisition strategy support growth. Find out why TMO stock is poised for continued ...

In a comprehensive Genomic Press Interview, distinguished psychiatrist Professor Peter Falkai suggests promising new ...

James Cook University researchers will target proteins secreted by hookworm larvae as part of an international effort to develop a game-changing ...

By inferring proliferation rates from single-cell genomics, SPRINTER enhances understanding of tumor evolution and identifies ...

Almirall, a global pharmaceutical company dedicated to medical dermatology, today announced the launch of “The Hive”, a novel scientific research hub located at its R&D centre in Barcelona, Spain. The ...

Digitalisation and AI in Orthopedic Surgery and Rehabilitation 4.0', and the rapidly evolving subject area, we are pleased to ...

The drug rapamycin is being studied for its antiaging and fertility-preserving benefits — and the results seem promising.

Groundbreaking studies in mice have sparked a frenzy among longevity enthusiasts—but human trials are still in their infancy.

The BHV-7000 study has had a Phase 1 trial by Biohaven Ltd. Fifty-eight patients — most of them middle-aged White men — ...